FDA Investigator Rafael E Arroyo
Rafael E Arroyo has inspections in 8 countries as of 13 Jul 2023. Rafael E Arroyo has collaborated with a combined 1843 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
20
Last Inspection Date:
13 Jul 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland,
United States of America,
Israel,
China,
Belgium,
India,
Italy,
Spain
Co-Investigator(s):
Alicia M Mozzachio,
Anastasia M Shields,
Andria L Kuhlman,
Arlene M Badillo,
Arsen Karapetyan,
Atul J Agrawal,
Azza Talaat,
Barbara J Rincon,
Burnell M Henry,
Carlos A Medina,
Charles I Ann,
Cheryl A Clausen,
Christopher S Keating,
Christopher T Middendorf,
Connie R Kiessling,
Dandan Wang, PhD,
David M Beltran,
Dipesh K Shah,
Dr. Barbara D Paul, PhD,
Dr. Carmelo Rosa,
Edmund F Mrak, Jr,
Edwin Melendez,
Emest F Bizjak,
Eric M Mueller, PharmD,
Felix Maldonado,
Gene R Gunn,
James L Dunnie, Jr,
Janete F Guardia,
Jay V Jariwala,
Jennifer Lalama,
Jocelyn E Massey,
Jonee J Mearns,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose E Melendez, DDC,
Jose Melendez,
José Meléndez,
Jose R Hernandez,
Jose R Lopez,
Jose Velez,
Katherine E Jacobitz,
Keith S Ehrlich,
Kellia N Hicks,
Kent C Faul,
Kham Phommachanh,
Laiza V Garcia,
Lawrence Harmon, Jr,
LCDR Chad N Thompson,
Leonard H Lavi,
Libia M Lugo,
Linda R Kuchenthal,
Lisa Hayka,
Lisa L Tung,
Lisa M Bellows,
Lloyd D Payne,
Margarita Santiago,
Marian E Ramirez,
Marie F Morin,
Massoud Motamed,
Matthew B Casale,
Meisha R Sampson,
Meisha Waters,
Merideth K Rose,
Michael A Taylor,
Miguel A Martinez,
Mra Munizn,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Nicole E Knowlton,
Noreen Muniz,
Norma Wong,
Norman Wong,
Patricia A Mcilroy,
Patrick C Klotzbuecher,
Paul L Figarole, Jr,
Paul Mouris,
Peter E Baker,
Pratik S Upadhyay, DDC,
Ralph A Erickson,
Ramon A Hernandez,
Raymond T Oji,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Robert D Tollefsen,
Robert J Martin,
Rochelle K Kimmel,
Saied A Asbagh,
Sandra A Hughes,
Satheesh Thomas,
Sena G Dissmeyer,
Sharon K Thoma, PharmD,
Simone E Pitts,
Sonia M Monges,
Steven A Gonzales,
Susan D Yuscius,
Susanna E Ford, Analyst,
Thomas J Arista,
Tiara Nbrown Crosen,
Wayne T Smith,
William A Warnick,
Xiaokuang Lai, PhD,
Zachary L Miller,
Zhongren Wu
Rafael E Arroyo's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2013 | FDA 483 | Ningbo Unichem Household Products Co Ltd. - Form 483, 2013-12-06 |
September, 2014 | FDA 483 | Tianjin Weijie Pharmaceutical Co., Ltd. - Form 483, 2014-09-12 |
May, 2009 | FDA 483 | TAPI Puerto Rico, Inc. - Form 483, 2009-05-19 |
June, 2009 | FDA 483 | Janssen-Cilag Manufacturing, LLC - Form 483, 2009-06-08 |
September, 2010 | FDA 483 | Teva Pharmaceutical Industries Ltd. - Form 483, 2010-09-16 |
November, 2015 | FDA 483 | Beijing Taiyang Pharmaceutical Industry Co. Ltd. - Form 483, 2015-11-19 |
March, 2015 | FDA 483 | Wockhardt Limited - Form 483, 2015-03-17 |
March, 2015 | EIR | Mylan Laboratories Limited - EIR, 2015-03-25 |
February, 2013 | FDA 483 | Novetide Ltd. - Form 483, 2013-02-07 |
March, 2015 | FDA 483 | Mylan Laboratories Limited - Form 483, 2015-03-25 |
May, 2014 | EIR | ITS Testing Services (UK) Limited - EIR, 2014-05-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more